Lilium N.V. Launches Capital Raise
Ticker: LILMF · Form: 6-K · Filed: May 23, 2024 · CIK: 1855756
Sentiment: neutral
Topics: capital-raise, funding
TL;DR
Lilium's raising cash, filing shows. Expect dilution.
AI Summary
On May 23, 2024, Lilium N.V. announced the launch of a capital raise. This announcement was made via a press release furnished as Exhibit 99.1 to their Form 6-K filing. The filing also includes Exhibit 99.2, which provides an update on certain business information for the company.
Why It Matters
This filing indicates Lilium is seeking additional funding, which could impact its ability to execute its business plan and potentially dilute existing shareholders.
Risk Assessment
Risk Level: medium — Capital raises can signal financial needs or strategic expansion, carrying inherent risks for investors.
Key Players & Entities
- Lilium N.V. (company) — Filer of the report and company launching capital raise
- May 23, 2024 (date) — Date of the press release announcing the capital raise
FAQ
What is the purpose of the capital raise announced by Lilium N.V.?
The filing does not specify the exact purpose of the capital raise, only that it has been launched.
When was the capital raise announced?
The capital raise was announced on May 23, 2024.
What exhibits are included with this Form 6-K filing?
This Form 6-K includes Exhibit 99.1 (press release announcing capital raise) and Exhibit 99.2 (update on business information).
What is Lilium N.V.'s principal executive office address?
Lilium N.V.'s principal executive office is located at Galileostraße 335, 82131 Gauting, Germany.
Does Lilium N.V. file annual reports under Form 20-F or 40-F?
Lilium N.V. indicates it files annual reports under Form 20-F.
Filing Stats: 618 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-05-23 16:33:30
Filing Documents
- tm2415262d1_6k.htm (6-K) — 13KB
- tm2415262d1_ex99-1.htm (EX-99.1) — 15KB
- tm2415262d1_ex99-2.htm (EX-99.2) — 49KB
- 0001104659-24-064734.txt ( ) — 79KB
Forward-Looking Statements
Forward-Looking Statements The information contained in this Report on Form 6-K and the Exhibits attached hereto contain certain forward-looking statements within the meaning of the U.S. federal securities laws, including, but not limited to, Lilium's contemplated offerings of securities and the consummation of the same. These forward-looking statements generally are identified by words such as "proposed," "contemplates," "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections, and other statements about future events that are based on management's current expectations with respect to future events and are based on assumptions and are subject to risks and uncertainties that are subject to change at any time. Actual events or results may differ materially from those contained in the forward-looking statements. Factors that could cause actual future events to differ materially from the forward-looking statements in this Report on Form 6-K and the Exhibits attached hereto include those risks and uncertainties discussed in Lilium's filings with the U.S. Securities and Exchange Commission (the "SEC"), including in the section titled "Risk Factors" in Lilium's Annual Report on Form 20-F for the year ended December 31, 2023, on file with the SEC, and similarly titled sections in Lilium's other SEC filings, all of which are available at www.sec.gov. Forward-looking statements speak only as of the date they are made. You are cautioned not to put undue reliance on forward-looking statements, and Lilium assumes no obligation to, and does not intend to, update, or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: May 23, 2024 Lilium N.V. By: /s/ Klaus Roewe Name: Klaus Roewe Title: Chief Executive Officer and Executive Director EXHIBIT INDEX Exhibit Number Description of Document 99.1 Press Release dated May 23, 2024 99.2 Business Overview Disclosure